Editor's key points † Continuous but non-invasive arterial pressure measurement offers some advantages during and after surgery. † This study evaluated such a device in patients with stable haemodynamics and found it performed satisfactorily. † Non-invasive continuous arterial pressure measurement might reduce the need for arterial cannulation in selected cases. † Non-invasive continuous arterial pressure measurement might provide more complete monitoring during and after surgery.
Mean arterial pressure (MAP) monitoring, along with pulse oximetric assessment of heart rate and arterial oxygen saturation, is mandatory in patients undergoing surgery, irrespective of the type of anaesthesia the patient receives. 1 During major surgical procedures or in high-risk patients, continuous (invasive) arterial pressure measurement using an indwelling arterial catheter is preferred to closely monitor 'beat-to-beat' changes in MAP. In addition, this method can be regarded as the clinical 'gold' standard for monitoring of MAP (MAP invasive ). However, placement of an indwelling arterial catheter is prone to several complications. 2 3 Thus, MAP invasive use is limited to patients in whom the advantage of continuous MAP measurement outweighs the risk of placement of the arterial catheter or when frequent arterial blood sampling is required.
In most cases, conventional non-invasive intermittent measurement of MAP by arm cuff oscillometry (MAP iNIAP ) with an interval of 3-5 min is considered appropriate. 1 In addition, it is not considered harmful (i.e. non-invasive) and easy to perform. Nevertheless, its accuracy is dependent on appropriate positioning of the patient, correct cuff positioning, and adequate cuff size, and may be impaired by patient conditions such as arrhythmia and obesity. 4 5 MAP iNIAP has been validated with the cuff placed around the upper arm; but since the upper arm may be inaccessible in some patients (due to wounds, fractures, oedema, vascular access), cuff locations on the calf or thigh are considered as alternative measurement sites, although they decrease measurement accuracy considerably. 5 On the top of decreased accuracy, MAP iNIAP does not allow continuous, 'beat-to-beat' monitoring of MAP as it takes time to inand deflate the cuff. Moreover, because cuff deflation takes several seconds, the determined systolic and diastolic values originate from different heartbeats and may therefore be inaccurate in situations where there is significant pulse pressure variation. 6 The Nexfin device (Edwards Lifesciences, Irvine, CA, USA), introduced in 2007, is based on the volume clamp method first introduced by the Czech physiologist Jan Penaz in 1967. 7 It allows continuous non-invasive arterial pressure measurement (MAP cNIAP ) using a photoplethysmograph and an inflatable cuff placed around a finger. 8 Based on the input from the photoplethysmograph, the cuff pressure is adjusted 1000 times per second to keep the arterial volume constant during the cardiac cycle. Thus, the artery is clamped at a diameter where the transmural pressure is zero, and therefore the cuff pressure is equal to the arterial pressure. This 'volume clamping' allows measurement of an arterial pressure waveform. Finally, brachial arterial pressure is reconstructed from finger arterial pressure and displayed. 9 Multiple studies 10 -12 have already investigated the accuracy of arterial pressure measurement by this device and compared it with invasively obtained measurements with various results. Yet, the vast majority of patients undergoing surgery is monitored solely using intermittent non-invasive measurements, and therefore, it is of interest whether MAP cNIAP would be a valuable adjunct or could ultimately replace MAP iNIAP in the intraoperative setting.
Therefore, we explored in the current study in patients under general anaesthesia, the agreement of both MAP cNIAP and MAP iNIAP with the clinical standard of arterial pressure measurement: MAP invasive measurement. In addition, we analysed whether the side of the measurement (i.e. contra-or ipsilateral to invasive measurement) of the MAP cNIAP finger cuff affected its accuracy.
Methods
This observational study was approved by the local medical ethics committee (METc 2011.052, University Medical Center Groningen, The Netherlands) and was registered at clinicaltrials.gov (NCT: 01362335).
A total of 120 patients, undergoing elective abdominal, neurosurgical, oncological, and vascular surgery under general anaesthesia and for which placement of a radial artery catheter was required on clinical grounds, were included ( Fig. 1 ). Measurements took place at an arbitrary moment of stable haemodynamic conditions during surgery with a total measurement period of 30 min. At least 24 h after the operation, written informed consent was obtained for analysis of the recorded data and patients were included for data analysis.
In all patients, anaesthesia was induced with propofol and sufentanil or remifentanil. Anaesthesia was maintained with propofol or sevoflurane, in combination with either sufentanil or remifentanil, as clinically required.
Before data recording, a radial artery was cannulated using a 20 G catheter and connected with a disposable pressure transducer (Truwave PX-600F, Edwards Lifesciences LLC). MAP iNIAP was measured using cuff oscillometry at the upper arm according to routine clinical practice with the cuff size adapted to body weight and posture, as recommended by the manufacturer. The MAP iNIAP measurement interval was set at 5 min.
The Nexfin cuff was placed at the intermediate phalanx, ipsi-or contralateral to the radial artery catheter, at the most accessible side.
To correct for hydrostatic pressure differences between the finger and the heart, the heart reference system (HRS TM ) is provided with the Nexfin device. Both the HRS TM and the arterial pressure transducer were located at the level of the right atrium.
MAP invasive and MAP iNIAP data were recorded at a 1 s and 5 min interval, respectively, using RugLoop II data-manager software (Demed, Temse, Belgium), connected to the anaesthesia monitor (Philips MP70; Philips, Eindhoven, The Netherlands). MAP cNIAP and other haemodynamic data (heart rate, cardiac index, systemic vascular resistance index, dP/dT ) were recorded in a beat-to-beat fashion on the Nexfin monitor. Values of MAP invasive , MAP iNIAP , and MAP cNIAP were imported into Microsoft Excel 2010 w (Microsoft, Redmond, WA, USA) and synchronized. After graphical representation of these values, a visual inspection was performed to correct for obvious atypical values caused by artifacts (mostly resulting from blood sampling and iNIAP cuff inflation).
Statistical analysis
All statistics were performed using Microsoft Excel 2010 w and PASW Statistics 18 (SPSS Inc., Chicago, IL, USA). A 30 s running median with 1 s steps was calculated for MAP invasive and MAP cNIAP . The normality of continuous variables was assessed using the Kolmogorov-Smirnov test. Data were expressed as mean (SD), median (range), or number of patients (%). The distribution (median, 2.5th and 97.5th percentile) of the difference with MAP invasive (either MAP cNIAP or MAP iNIAP minus MAP invasive ) was plotted for the 30 min time period. The Mann -Whitney U-test was performed to test whether the difference in the bias of both methods was significantly different. A modified Bland -Altman analysis for repeated measurements 13 -15 was performed for comparison of all data points of MAP cNIAP with MAP invasive and of MAP iNIAP with MAP invasive at a 5 min time interval. In a case where cuff inflation influenced continuous measurements, these variables were determined just before inflation of the cuff and correlated with the subsequent MAP iNIAP value. Here, the bias (SD) is calculated together with the limits of agreement [LOA¼bias (1.96 SD)]. As a measure of precision, 16 coefficients of error (CE) were calculated as the SD of the bias divided by the mean of measurements. Subsequently, percentage errors for MAP cNIAP and MAP iNIAP compared with MAP invasive were calculated as: 2.0×CE×100; here CE is from either MAP cNIAP or MAP iNIAP bias. 17 Currently, two guidelines apply to validation of arterial pressure measurement by the Nexfin: one from the European Working Group for the Validation of Blood Pressure Measuring Devices (ESH criteria) and one from the Association for the Advancement of Medical Instrumentation (AAMI). 18 19 The requirements for validation by the ESH criteria are summarized in the legend of Table 1 . Furthermore, AAMI criteria consider a device acceptable if its estimated probability of tolerable error is at least 85%, suggesting that a predefined estimated sample mean error of 5 mm Hg should have a concomitant standard deviation below 8 mm Hg. We used this criterion to test for non-inferiority. Sample size calculation for our study was based on the AAMI criteria and was calculated in order to detect a mean difference of 5 mm Hg. For an estimated SD of MAP values of 9 mm Hg, a power of 98% and an a-error of 0.05, at least 106 patients should be included. Therefore, we included 120 patients in total. Statistical significance was assumed if P,0.05.
Results
A total of 120 patients were included in this study ( Fig. 1 ). Eight patients were excluded from data analysis because of unwillingness or inability to sign informed consent (n¼7) or technical reasons (n¼1). Of the 112 patients analysed in total, two data sets could not be used for the comparison of MAP cNIAP with MAP invasive and 11 data sets could not be used for the comparison of MAP iNIAP with MAP invasive , all because of technical difficulties with recording MAP cNIAP or MAP iNIAP , respectively. Characteristics of the studied patients (n¼112) were normally Continuous non-invasive arterial pressure measurement distributed and are shown together with the main haemodynamic variables in Table 2 . Figure 2 shows the individual differences with MAP invasive values of MAP cNIAP ( Fig. 2A ) and MAP iNIAP measurements (Fig. 2B ) for the 30 min measurement period of all patients together with its median and concomitant 2.5th and 97.5th percentile.
The median difference (2.5th/97.5th percentile) of MAP cNIAP at the start of measurements was 1 (213/8) mm Hg and was 3 (28/11) mm Hg after 30 min. The median difference of MAP iNIAP was 22 (218/14) mm Hg at the start of measurements and was 22 (218/8) mm Hg after 30 min. For all data points, the bias of MAP cNIAP was significantly different from that of MAP iNIAP (P,0.001, Mann-Whitney U-test).
In Figure 3 and Table 3 , the bias (SD) and LOAs, as derived from the modified Bland -Altman analysis for repeated measurements, are shown for the 30 min time period with a time interval of 5 min. Also in Table 3 , CE and percentage errors for both MAP cNIAP and MAP iNIAP are shown. The original modified Bland -Altman plot, including all available data points, is shown in Supplementary Figure S1 .
The performance of both MAP cNIAP and MAP iNIAP measurement as an alternative for MAP invasive is shown in Table 1 for both steps of the ESH reliability criteria. Neither MAP cNIAP nor MAP iNIAP measurements succeeded to match any of these criteria. Both measurement methods also failed to meet the AAMI criteria ( Table 3 ).
Influence of measurement side and absolute MAP invasive value on MAP cNIAP bias
The Nexfin w cuff was attached to the index finger ipsilateral to the inserted radial artery catheter in 70 patients (63%), whereas it was attached to the contralateral side in 42 patients (37%). The modified Bland -Altman analysis for repeated measurements revealed no differences in agreement of MAP cNIAP with MAP invasive between both measurement sides: bias (SD) was 2 (9) (LOA: 216/20) mm Hg for ipsilateral and 2 (8) (LOA: 214/18) mm Hg for contralateral measurements. Figure 4 shows the influence of MAP invasive on MAP cNIAP accuracy. Values are shown for all data points (n¼765) in the 30 min measurement period with an interval of 5 min. There was no correlation between the two variables, indicating that MAP invasive had no effect on the accuracy of cNIAP.
Discussion
The agreement of the Nexfin device with invasive arterial pressure measurement as a gold standard has been studied in several recent studies, with varying results. However, much as replacement of invasive by non-invasive measurement has important advantages, most patients undergoing anaesthesia are monitored in a non-invasive fashion, and may benefit from accurate and precise continuous non-invasive monitoring. To the best of our knowledge, this is the first study investigating the potential benefit of the Nexfin to monitor arterial pressure for these patients.
In the current study in patients under general anaesthesia, the main purpose was to quantify the accuracy and precision of continuous non-invasive MAP measurement using the Nexfin device (MAP cNIAP ) and using conventional intermittent cuff oscillometry (MAP iNIAP ), comparing both methods with the gold standard, that is, continuous invasive measurement of MAP (MAP invasive ). Only periods of stable haemodynamic conditions were recorded and included for further analysis.
In this phase, the Nexfin-derived MAP cNIAP showed an agreement with invasive measurements which was not inferior to the agreement of automated cuff oscillometry-derived MAP iNIAP . This suggests that this method is at least a valuable adjunct to measure MAP and might even be used as an alternative to MAP iNIAP in patients undergoing anaesthesia. We observed however that both MAP iNIAP and MAP cNIAP showed some imprecision with respect to invasive MAP measurement (MAP invasive ) and that both methods failed to meet the AAMI criteria and the ESH criteria for arterial pressure measurement validation.
The accuracy of Nexfin-derived MAP cNIAP measurements has been studied in a number of previous studies 10 11 12 20 -23 and showed close correlations with MAP invasive in patients undergoing cardiothoracic surgery, 11 and was considered reliable enough to replace invasive arterial pressure monitoring in most patients. 24 MAP cNIAP and MAP iNIAP accuracy have until now only been compared in awake-non-anaesthetized-patients, and in these studies, they were not compared with any gold standard.
Studies comparing MAP cNIAP with MAP iNIAP in supine patients, 25 in acutely ill patients at an emergency department, 24 in pregnant women for longitudinal tracking of arterial pressure, 26 or in patients during autonomic function testing 27 demonstrated adequate accuracies.
We however did not investigate the relationship between MAP cNIAP and MAP iNIAP measurements as in our opinion, it is more relevant-in patients receiving (general) anaesthesiato directly compare both MAP cNIAP and MAP iNIAP measurements ) . Surprisingly, we found that both non-invasive measurement methods failed to meet the AAMI criteria because the precision-as an indication of measurement reproducibility-exceeded the pre-defined precision of 8 mm Hg. Nevertheless, MAP cNIAP values were more closely related to MAP invasive values than the MAP iNIAP values, which was also true for the agreement data provided in Tables 1 and 3 . While statistically significant, the small absolute difference does not entail a clinically significant superior accuracy. There are, up to our knowledge, no other studies in which the accuracy of both MAP cNIAP and MAP iNIAP measurements were compared with MAP invasive measurements and therefore, these findings require confirmation in future studies, particularly in conditions of haemodynamic instability and during vasopressor use. A second point of major clinical importance is that while the difference in accuracy of both non-invasive methods is small and arguably not clinically significant, MAP cNIAP monitoring has the obvious advantage of providing MAP measurements both faster and in a continuous 'beat-to-beat' fashion.
In this view, although inevitably less accurate than MAP invasive , showing non-inferiority of absolute measurement of the MAP cNIAP relative to MAP iNIAP would be sufficient to advocate its use.
As pointed out in a recent study, 28 MAP cNIAP was able to detect significantly more periods of hypo-and hypertension in patients undergoing surgery compared with the use of MAP iNIAP monitoring. Additionally, the Nexfin device can also obtain flow-based haemodynamic variables such as cardiac output, although reports on the accuracy of these variables are sparse. Since MAP cNIAP is acquired at the finger, and the MAP invasive at the radial artery, while MAP iNIAP is measured at the brachial level, one may ask whether the reported superior agreement with invasive measurements is merely a Continuous non-invasive arterial pressure measurement consequence of the reference point. The Nexfin algorithm however performs a waveform transformation to reconstruct the arterial waveform and values, and therefore, MAP cNIAP and MAP iNIAP values should be considered brachial MAP. In addition, since the higher errors in MAP iNIAP consist of overestimations and underestimations (Fig. 2) , a difference in reference point is an unlikely reason for the divergent accuracy. Still, non-inferiority of MAP cNIAP compared with MAP iNIAP does not necessarily result in improved patient outcome, but a faster diagnosis 29 implicates a significant potential for improved patient monitoring. An additional advantage is likely in patients where brachial measurements may be difficult such as obese patients or patients with brachial injuries or dialysis shunts. However, it has to be shown if the additional costs of measuring MAP cNIAP justify the benefits of its use described above, also in view of a recent change in the distributer of the device.
Study limitations
All measurements were performed in patients at arbitrary moments during general anaesthesia. The most important limitation therefore is that during these observation periods, no particularly considerable changes in arterial pressure occurred and therefore the accuracy and precision of both MAP cNIAP and MAP iNIAP during substantial variations in arterial pressure cannot be answered by this study. It has been demonstrated that the use of continuous non-invasive measurements decreases the total time of hypotension or hypertension during anaesthesia significantly, but the accuracy of either assessments compared with a gold standard was not investigated in that study. 30 Secondly, our measurements took place in patients with MAP invasive at randomly selected moments during anaesthesia. We did not specifically analyse the influence of changes in vascular tone, for example, induced by changes in temperature or use of vasoactive drugs. This is, however, in accordance with normal clinical practice where reliability of MAP iNIAP may also be dependent on a variety of physiological conditions. Although the Physiocal algorithm of the Nexfin monitor is developed to compensate for any changes in vascular tone due to peripheral hypothermia or other induced changes in local perfusion, we may not exclude a decrease in accuracy of finger-based methods in such cases. Therefore, our conclusions are only valid for normothermic, haemodynamically stable patients not requiring (high doses of) vasoactive medication.
It is well known that pulse oximetry becomes less accurate in the case of hyperpigmentation, low blood oxygen saturation, or certain intoxications because pulse oximetry is based on differential absorption of two distinct wavelengths. The plethysmographic measurement used for the volume clamp method, however, does not rely on such delicately distinct wavelength absorptions (it uses one wavelength only) and is therefore very unlikely to be less reliable in such circumstances, although no reports have confirmed this yet. Despite the reliability of MAP cNIAP compared with MAP iNIAP , our results also show that the agreement of MAP cNIAP with MAP invasive is not sufficient to advocate replacing MAP invasive in any case. Therefore, high-risk patients undergoing major procedures, that is, conditions where hypothermia or high vasopressor need may occur, will still require invasive MAP monitoring for most reliable arterial pressure monitoring and arterial blood sampling.
Furthermore, insufflation of the MAP iNIAP cuff is known to induce alterations in the vascular compliance due to endothelial activation and vasodilation. Our previous research demonstrates a sustained influence on distal limb physiology for several minutes after intermittent MAP iNIAP cuff insufflation. 31 It is still the subject of debate whether these microvascular changes are induced by ischaemia, congestion, or other physiological phenomena, but it is conceivable that these local changes may influence the compliance of the vascular wall and therefore the accuracy of the MAP cNIAP measurements. Contrarily, inter-arm anatomical differences can also cause different arterial pressure readings. 32 Therefore, we measured MAP cNIAP either ipsilaterally and contralaterally with regard to MAP invasive . Since there was no blinded randomization on this matter, this may have influenced our results. However, a subanalysis comparing data received from the ipsilateral vs contralateral side did not reveal any significant differences. Hence, we decided to group all data without further differentiating the side of MAP cNIAP measurement.
Finally, all analyses were performed on MAP values, since these are most commonly used in comparing different monitoring devices 33 and also for guiding therapy. Comparison of systolic arterial pressure values may vary somewhat from our results, although these were not reported for conciseness.
Conclusion
This study shows that in a haemodynamically stable phase in patients under general anaesthesia, the agreement with invasive MAP measurements of Nexfin-derived MAP cNIAP was found to be non-inferior to conventional MAP iNIAP measurements. Although influence on outcome was not investigated, this study demonstrates that MAP cNIAP has significant potential to improve patient monitoring in haemodynamically stable patients undergoing anaesthesia where MAP iNIAP is at present being clinically used.
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